Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс:
https://elar.urfu.ru/handle/10995/141720
Полная запись метаданных
Поле DC | Значение | Язык |
---|---|---|
dc.contributor.author | Zayed, A. | en |
dc.contributor.author | Al-Saedi, D. A. | en |
dc.contributor.author | Mensah, E. O. | en |
dc.contributor.author | Kanwugu, O. N. | en |
dc.contributor.author | Adadi, P. | en |
dc.contributor.author | Ulber, R. | en |
dc.date.accessioned | 2025-02-25T11:02:22Z | - |
dc.date.available | 2025-02-25T11:02:22Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | Zayed, A., Al-Saedi, D. A., Mensah, E., Kanwugu, O., Adadi, P., & Ulber, R. (2024). Fucoidan’s Molecular Targets: A Comprehensive Review of Its Unique and Multiple Targets Accounting for Promising Bioactivities Supported by In Silico Studies. Marine Drugs, 22(1), [29]. https://doi.org/10.3390/md22010029 | apa_pure |
dc.identifier.issn | 1660-3397 | - |
dc.identifier.other | Final | 2 |
dc.identifier.other | All Open Access; Gold Open Access; Green Open Access | 3 |
dc.identifier.other | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85183085868&doi=10.3390%2fmd22010029&partnerID=40&md5=e0ed6888a86841ac878e1e4b4d40615c | 1 |
dc.identifier.other | https://www.mdpi.com/1660-3397/22/1/29/pdf?version=1703923666 | |
dc.identifier.uri | http://elar.urfu.ru/handle/10995/141720 | - |
dc.description.abstract | Fucoidan is a class of multifunctional polysaccharides derived from marine organisms. Its unique and diversified physicochemical and chemical properties have qualified them for potential and promising pharmacological uses in human diseases, including inflammation, tumors, immunity disorders, kidney diseases, and diabetes. Physicochemical and chemical properties are the main contributors to these bioactivities. The previous literature has attributed such activities to its ability to target key enzymes and receptors involved in potential disease pathways, either directly or indirectly, where the anionic sulfate ester groups are mainly involved in these interactions. These findings also confirm the advantageous pharmacological uses of sulfated versus non-sulfated polysaccharides. The current review shall highlight the molecular targets of fucoidans, especially enzymes, and the subsequent responses via either the upregulation or downregulation of mediators’ expression in various tissue abnormalities. In addition, in silico studies will be applied to support the previous findings and show the significant contributors. The current review may help in understanding the molecular mechanisms of fucoidan. Also, the findings of this review may be utilized in the design of specific oligomers inspired by fucoidan with the purpose of treating life-threatening human diseases effectively. © 2023 by the authors. | en |
dc.format.mimetype | application/pdf | en |
dc.language.iso | en | en |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | en |
dc.rights | info:eu-repo/semantics/openAccess | en |
dc.rights | cc-by | other |
dc.source | Marine Drugs | 2 |
dc.source | Marine Drugs | en |
dc.subject | BIOACTIVITIES | en |
dc.subject | FUCOIDAN | en |
dc.subject | INFLAMMATION MARKERS | en |
dc.subject | MOLECULAR MECHANISMS | en |
dc.subject | SIGNALING PATHWAYS | en |
dc.subject | DOWN-REGULATION | en |
dc.subject | ESTERS | en |
dc.subject | HUMANS | en |
dc.subject | INFLAMMATION | en |
dc.subject | POLYSACCHARIDES | en |
dc.subject | SULFATES | en |
dc.subject | 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE | en |
dc.subject | ADEZMAPIMOD | en |
dc.subject | ALPHA INTERFERON | en |
dc.subject | ALPHA SMOOTH MUSCLE ACTIN | en |
dc.subject | CATALASE | en |
dc.subject | CONNECTIVE TISSUE GROWTH FACTOR | en |
dc.subject | CYCLIN D1 | en |
dc.subject | CYCLIN DEPENDENT KINASE 4 | en |
dc.subject | CYCLIN DEPENDENT KINASE 6 | en |
dc.subject | CYCLIN E | en |
dc.subject | CYCLOOXYGENASE 1 | en |
dc.subject | CYCLOOXYGENASE 2 | en |
dc.subject | EPIDERMAL GROWTH FACTOR | en |
dc.subject | EPIDERMAL GROWTH FACTOR RECEPTOR | en |
dc.subject | FUCOIDIN | en |
dc.subject | G PROTEIN COUPLED RECEPTOR | en |
dc.subject | GAMMA INTERFERON | en |
dc.subject | GLUCOSE TRANSPORTER 4 | en |
dc.subject | GLUTATHIONE PEROXIDASE | en |
dc.subject | GLYCOGEN SYNTHASE KINASE 3BETA | en |
dc.subject | HEME OXYGENASE 1 | en |
dc.subject | IMMUNOGLOBULIN ENHANCER BINDING PROTEIN | en |
dc.subject | INDOMETACIN | en |
dc.subject | INDUCIBLE NITRIC OXIDE SYNTHASE | en |
dc.subject | INTERLEUKIN 12 | en |
dc.subject | INTERLEUKIN 1BETA | en |
dc.subject | INTERLEUKIN 6 | en |
dc.subject | KELCH LIKE ECH ASSOCIATED PROTEIN 1 | en |
dc.subject | LAPATINIB | en |
dc.subject | MACROPHAGE DERIVED CHEMOKINE | en |
dc.subject | MALONALDEHYDE | en |
dc.subject | MITOGEN ACTIVATED PROTEIN KINASE | en |
dc.subject | MITOGEN ACTIVATED PROTEIN KINASE 1 | en |
dc.subject | MITOGEN ACTIVATED PROTEIN KINASE 3 | en |
dc.subject | MYELOID DIFFERENTIATION FACTOR 88 | en |
dc.subject | NEUROPILIN 1 | en |
dc.subject | NEUROPILIN 2 | en |
dc.subject | OLIGOMER | en |
dc.subject | PATHOGEN ASSOCIATED MOLECULAR PATTERN | en |
dc.subject | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA | en |
dc.subject | PHOSPHATIDYLINOSITOL 3 KINASE | en |
dc.subject | PLATELET DERIVED GROWTH FACTOR | en |
dc.subject | POLYSACCHARIDE | en |
dc.subject | PROTEIN BAX | en |
dc.subject | PROTEIN BCL 2 | en |
dc.subject | PROTEIN KINASE B | en |
dc.subject | RAB PROTEIN | en |
dc.subject | RAS PROTEIN | en |
dc.subject | REACTIVE OXYGEN METABOLITE | en |
dc.subject | SMAD2 PROTEIN | en |
dc.subject | SMAD3 PROTEIN | en |
dc.subject | SMAD4 PROTEIN | en |
dc.subject | SUPEROXIDE DISMUTASE | en |
dc.subject | TOLL LIKE RECEPTOR 2 | en |
dc.subject | TOLL LIKE RECEPTOR 4 | en |
dc.subject | TRANSCRIPTION FACTOR NRF2 | en |
dc.subject | TRANSCRIPTION FACTOR RELA | en |
dc.subject | TUMOR NECROSIS FACTOR | en |
dc.subject | VASCULOTROPIN | en |
dc.subject | ESTER | en |
dc.subject | FUCOIDIN | en |
dc.subject | POLYSACCHARIDE | en |
dc.subject | SULFATE | en |
dc.subject | 3T3-L1 CELL LINE | en |
dc.subject | A-549 CELL LINE | en |
dc.subject | ALZHEIMER DISEASE | en |
dc.subject | ANGIOGENESIS | en |
dc.subject | ANTIINFLAMMATORY ACTIVITY | en |
dc.subject | APOPTOSIS | en |
dc.subject | ARPE-19 CELL LINE | en |
dc.subject | AUTOIMMUNE DISEASE | en |
dc.subject | BINDING AFFINITY | en |
dc.subject | BIOLOGICAL ACTIVITY | en |
dc.subject | BREAST CANCER | en |
dc.subject | CARDIOVASCULAR DISEASE | en |
dc.subject | CATARACT | en |
dc.subject | CELL GROWTH | en |
dc.subject | CELL MIGRATION | en |
dc.subject | CELL PROLIFERATION | en |
dc.subject | CELL SURVIVAL | en |
dc.subject | CHROMOSOME ABERRATION | en |
dc.subject | COMPUTER MODEL | en |
dc.subject | DIABETES MELLITUS | en |
dc.subject | DNA BINDING | en |
dc.subject | DOWN REGULATION | en |
dc.subject | DROSOPHILA MELANOGASTER | en |
dc.subject | DU145 CELL LINE | en |
dc.subject | ENDOCYTOSIS | en |
dc.subject | EPITHELIAL MESENCHYMAL TRANSITION | en |
dc.subject | ERYTHROLEUKEMIA | en |
dc.subject | HEAT SHOCK | en |
dc.subject | HEMATOPOIESIS | en |
dc.subject | HEP-G2 CELL LINE | en |
dc.subject | HUVEC CELL LINE | en |
dc.subject | HYPEROXIA-INDUCED LUNG INJURY | en |
dc.subject | HYPERTENSION | en |
dc.subject | INFLAMMATION | en |
dc.subject | IONIZING RADIATION | en |
dc.subject | KIDNEY DISEASE | en |
dc.subject | L-02 CELL LINE | en |
dc.subject | LIVER CELL CARCINOMA | en |
dc.subject | LIVER FIBROSIS | en |
dc.subject | LIVER NECROSIS | en |
dc.subject | LUNG CANCER | en |
dc.subject | MAPK SIGNALING | en |
dc.subject | MCF-7 CELL LINE | en |
dc.subject | MDA-MB-231 CELL LINE | en |
dc.subject | MELANOMA | en |
dc.subject | METABOLIC SYNDROME X | en |
dc.subject | METASTATIC COLORECTAL CANCER | en |
dc.subject | MICROGLIA | en |
dc.subject | MOLECULAR DOCKING | en |
dc.subject | MTOR SIGNALING | en |
dc.subject | NCI-H1650 CELL LINE | en |
dc.subject | NF KB SIGNALING | en |
dc.subject | NK-92 CELL LINE | en |
dc.subject | NONHUMAN | en |
dc.subject | OSSIFICATION | en |
dc.subject | OSTEOPOROSIS | en |
dc.subject | OXIDATIVE STRESS | en |
dc.subject | PANCREAS CANCER | en |
dc.subject | PHYSICAL CHEMISTRY | en |
dc.subject | PI3K/AKT SIGNALING | en |
dc.subject | PROTEIN PHOSPHORYLATION | en |
dc.subject | RAW 264.7 CELL LINE | en |
dc.subject | RETINAL PIGMENT EPITHELIUM | en |
dc.subject | REVIEW | en |
dc.subject | RHEUMATOID ARTHRITIS | en |
dc.subject | SH-SY5Y CELL LINE | en |
dc.subject | TGF BETA SIGNALING | en |
dc.subject | ULTRAVIOLET RADIATION | en |
dc.subject | UPREGULATION | en |
dc.subject | HUMAN | en |
dc.subject | INFLAMMATION | en |
dc.title | Fucoidan’s Molecular Targets: A Comprehensive Review of Its Unique and Multiple Targets Accounting for Promising Bioactivities Supported by In Silico Studies | en |
dc.type | Article | en |
dc.type | info:eu-repo/semantics/article | en |
dc.type | info:eu-repo/semantics/publishedVersion | en |
dc.identifier.doi | 10.3390/md22010029 | - |
dc.identifier.scopus | 85183085868 | - |
local.contributor.employee | Zayed A., Institute of Bioprocess Engineering, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Gottlieb-Daimler-Straße 49, Kaiserslautern, 67663, Germany, Department of Pharmacognosy, College of Pharmacy, Tanta University, El-Guish Street (Medical Campus), Tanta, 31527, Egypt | en |
local.contributor.employee | Al-Saedi D.A., Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia | en |
local.contributor.employee | Mensah E.O., Faculty of Ecotechnology, ITMO University, Lomonosova Street 9, Saint Petersburg, 191002, Russian Federation | en |
local.contributor.employee | Kanwugu O.N., Institute of Chemical Engineering, Ural Federal University, Mira Street 28, Yekaterinburg, 620002, Russian Federation, ARC Centre of Excellence in Synthetic Biology, School of Natural Sciences, Macquarie University, Sydney, 2109, NSW, Australia | en |
local.contributor.employee | Adadi P., Department of Food Science, University of Otago, Dunedin, 9054, New Zealand | en |
local.contributor.employee | Ulber R., Institute of Bioprocess Engineering, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Gottlieb-Daimler-Straße 49, Kaiserslautern, 67663, Germany | en |
local.issue | 1 | - |
local.volume | 22 | - |
dc.identifier.wos | 001151140200001 | - |
local.contributor.department | Institute of Bioprocess Engineering, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Gottlieb-Daimler-Straße 49, Kaiserslautern, 67663, Germany | en |
local.contributor.department | Department of Pharmacognosy, College of Pharmacy, Tanta University, El-Guish Street (Medical Campus), Tanta, 31527, Egypt | en |
local.contributor.department | Department of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia | en |
local.contributor.department | Faculty of Ecotechnology, ITMO University, Lomonosova Street 9, Saint Petersburg, 191002, Russian Federation | en |
local.contributor.department | Institute of Chemical Engineering, Ural Federal University, Mira Street 28, Yekaterinburg, 620002, Russian Federation | en |
local.contributor.department | ARC Centre of Excellence in Synthetic Biology, School of Natural Sciences, Macquarie University, Sydney, 2109, NSW, Australia | en |
local.contributor.department | Department of Food Science, University of Otago, Dunedin, 9054, New Zealand | en |
local.identifier.pure | 52291891 | - |
local.description.order | 29 | |
local.identifier.eid | 2-s2.0-85183085868 | - |
local.identifier.wos | WOS:001151140200001 | - |
local.identifier.pmid | 38248653 | - |
Располагается в коллекциях: | Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC |
Файлы этого ресурса:
Файл | Описание | Размер | Формат | |
---|---|---|---|---|
2-s2.0-85183085868.pdf | 2,75 MB | Adobe PDF | Просмотреть/Открыть |
Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.